Daytrana (Noven Therapeutics, LLC)


Welcome to the PulseAid listing for the Daytrana drug offered from Noven Therapeutics, LLC. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Noven Therapeutics, LLC
NON-PROPRIETARY NAME: methylphenidate
SUBSTANCE NAME: METHYLPHENIDATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE]
ROUTE: TRANSDERMAL
DOSAGE FORM: PATCH
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2006-04-06
END MARKETING DATE: 0000-00-00


Daytrana HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDaytrana from Noven Therapeutics, LLC
LABELER NAME: Noven Therapeutics, LLC
DEA SCHEDULE: CII
ACTIVE STRENGTH: 10(mg/9h)
START MARKETING DATE: 2006-04-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68968-5552_2a1c054c-fb18-46a1-a776-b20414ff3dc9
PRODUCT NDC: 68968-5552
APPLICATION NUMBER: NDA021514

Other METHYLPHENIDATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Neos Therapeutics, LPCotempla XR-ODT
Noven Therapeutics, LLCDaytrana